BioCentury | Jun 17, 2013
Strategy

Externalizing Astellas

...and Drais formed two other virtual companies - Seldar Pharma Inc. to develop and commercialize ASP7147...
...diarrhea; and Telsar Pharmaceuticals Inc. to develop and commercialize Astellas' ulcerative colitis compound ASP3291 . ASP7147...
BioCentury | May 13, 2013
Company News

Drais, Tacurion, Astellas deal

...for ulcerative colitis (UC) and Seldar Pharma Inc. (Bridgewater, N.J.) to develop and commercialize Astellas' ASP7147...
BioCentury | May 8, 2013
Company News

Astellas, Drais form newco to develop Astellas nocturia compound

...for ulcerative colitis (UC) and Seldar Pharma Inc. (Bridgewater, N.J.) to develop and commercialize Astellas' ASP7147...
BioCentury | Jun 11, 2012
Company News

Drais, Seldar, Astellas deal

...to form virtual company - Seldar Pharma Inc. - that will develop and commercialize Astellas' ASP7147...
BioCentury | Jun 5, 2012
Company News

Astellas, Drais form newco to develop Astellas' IBS product

...to form virtual company -- Seldar Pharma Inc. -- that will develop and commercialize Astellas' ASP7147...
Items per page:
1 - 5 of 5